Remdesivir to be administered on medical prescription to severe COVID-19 patients : Centre to SC
A bench headed by Justice D Y Chandrachud was informed that there is a growing demand from some quarters to permit the use of Remdesivir even when a person is taking treatment at his own home.
Share Via Email
| A+A A- By PTI
NEW DELHI: Antiviral drug Remdesivir is to be administered only after a medical prescription and limited to severe condition of COVID-19 patients strictly as per medical protocol, the Centre told the Supreme Court on Friday.
A bench headed by Justice D Y Chandrachud was informed that there is a growing demand from some quarters to permit the use of Remdesivir even when a person is taking treatment at his own home under his own private medical supervision.
Remdesivir to be administered to severe COVID-19 patients with prescriptions: Centre tells SC
A bench headed by Justice D Y Chandrachud was informed that there is a growing demand from some quarters to permit the use of Remdesivir even when a person is taking treatment at his own home under his own private medical supervision
PTI | April 30, 2021 | Updated 21:49 IST
Remdesivir is listed as investigational therapy in the National Clinical Management Protocol: COVID-19
Antiviral drug Remdesivir is to be administered only after a medical prescription and limited to severe condition of COVID-19 patients strictly as per medical protocol, the Centre told the Supreme Court on Friday.
Antiviral drug Remdesivir is to be administered only after a medical prescription and limited to severe condition of Covid-19 patients strictly as per medical protocol, the Centre told the Supreme Court on Friday.
NEW DELHI: Antiviral drug Remdesivir is to be administered only after a medical prescription and limited to severe condition of Covid-19 patients strictly as per medical protocol, the Centre told the Supreme Court on Friday. A bench headed by Justice D Y Chandrachud was informed that there is a growing demand from some quarters to permit the use of Remdesivir even when a person is taking treatment at his own home under his own private medical supervision.
India s cumulative vaccination coverage exceeds 13 cr ANI | Updated: Apr 20, 2021 23:12 IST
New Delhi [India], April 20 (ANI): The cumulative number of COVID-19 vaccine doses administered in the country has crossed 13 crores on Tuesday, said the Ministry of Health and Family Welfare.
According to the ministry, the cumulative number of COVID-19 vaccine doses administered in the country stands at 13,00,27,370 as per the 9 pm provisional report today. More than 28.98 lakh vaccine doses administered till 9 pm.
Total 71,051 COVID vaccination Centres (CVCs) were operational, marking a rise of more than 26,051 operational vaccination centres. Workplace vaccinations have also enabled such a high turnout of beneficiaries.
These include 92,01,040 Healthcare Workers (HCWs) who have taken the 1st dose and 58,16,538 HCWs who have taken the second dose, 1,15,59,218 Frontline Workers (FLWs) who received the first dose, and 58,52,669 FLWs who received the
Nawab Malik of Center Blocking Remediesvir Supply to Maharashtra, Colleges NCP
0 0 3 minutes read
Center warns export companies against the supply of Remedisvir to Maharashtra, Nawab Malik alleges (File)
Mumbai:
Nationalist Congress Party (NCP) leader and Maharashtra minister Nawab Malik alleged on Saturday that the central government had asked export companies not to supply antiviral drug remediesvir in the state as Maharashtra also recorded the highest number of daily cases. Have been.
The BJP, which is in power at the Center, was more interested in winning elections than in dealing with the coronovirus crisis.
The BJP said that Nawab Malik should either give evidence or apologize for the “false” and “baseless” allegations, adding that the minister should step down from his post.